QHSLab (OTCQB: USAQ) Rolls Out Breakthrough Pediatric Screening Tool Linking Allergies and Mental Health Sep 2, 2025 12:58PM
QHSLab, Inc. Announces Preliminary Unaudited First Quarter Revenue Results Apr 26, 2024 08:30AM
QHSLab, Inc. Reports First Quarter Financial Results May 15, 2023 08:00AM
QHSLab, Inc. Announces Representation Agreement with Healthcare Information Technology Specialists of Florida Feb 16, 2023 08:30AM
QHSLab, Inc. Reiterates its 2022 Projection of a $7.5 Billion Addressable Market for its Integrated Service Program (ISP) Digital Health Solution Designed For Primary Care Jan 30, 2023 08:30AM


Nov 14, 2022 08:30AM QHSLab, Inc. Projects a $7.5 Billion Addressable Market for its Integrated Service Program (ISP) Digital Health Solution Designed For Primary Care
Nov 1, 2022 08:30AM QHSLab, Inc. Meets the Demand for Updated Mental Health Screening Recommendations from the U.S. Preventive Services Task Force
Sep 20, 2022 08:30AM QHSLab, Inc. Launches a “Long COVID” Digital Health Tool for Primary Care Physicians
Jun 24, 2022 08:30AM QHSLab Announces New Strategic Alliance with Medical License Factory For its AllergiEnd® Products and Services
May 24, 2022 08:00AM QHSLab, Inc’s CEO Addresses Current Market Conditions & Recent Quarterly Performance
May 10, 2022 08:30AM New $90 million annual addressable market for QHSLab’s latest product, the Allergy Quick Test, branded AllergiQT™.
May 9, 2022 08:30AM QHSLab. Issues Update and Investor Presentation May 2022